Margareta Spjut
@Healthinvest Partners Ab
Latest period2024 - Q3ReportedManaged Assets$212.751MTotal holdings36
Assets growth rate29.73%Assets growth rate (2-Q avg)14.76%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Healthinvest Partners Ab's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.
Assets under management
The assets under management (AUM) of Healthinvest Partners Ab over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 212.751M in assets, with a quarterly growth rate of 29.73% and a 2-quarter average growth rate of 14.76%. The portfolio is managed by Margareta Spjut, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
LLYEli Lilly & Co
| 12.73% | $27.078M 30,564 shares@ $885.94 avg price | Increased 12.6% |
UNHUnitedhealth Group Inc
| 9.76% | $20.75M 35,490 shares@ $584.68 avg price | Increased 12.03% |
MRKMerck & Co Inc
| 8.26% | $17.568M 154,699 shares@ $113.56 avg price | Increased 37.23% |
TMOThermo Fisher Scientific Inc
| 6.4% | $13.616M 22,012 shares@ $618.58 avg price | Increased 13.13% |
AMGNAmgen Inc
| 4.39% | $9.333M 28,965 shares@ $322.22 avg price | Increased 4.99% |
ABBVAbbvie Inc
| 4.13% | $8.785M 44,486 shares@ $197.48 avg price | Increased 24.9% |
SYKStryker Corporation
| 3.99% | $8.475M 23,460 shares@ $361.27 avg price | Increased 17.4% |
CORCencora Inc
| 3.87% | $8.225M 36,544 shares@ $225.09 avg price | Increased 20.53% |
VRTXVertex Pharmaceuticals Inc
| 3.72% | $7.903M 16,993 shares@ $465.08 avg price | Increased 12.58% |
REGNRegeneron Pharmaceuticals
| 3.48% | $7.388M 7,028 shares@ $1051.25 avg price | Increased 1.96% |